Previous 10 |
home / stock / nicxf / nicxf news
Nicox ( OTCPK:NICXF ): Q3 Revenue of $0.44M More news on: NICOX SA EUR ORD NEW, Earnings news and commentary, Healthcare stocks news, , Read more ...
The FDA approves Sun Pharmaceuticals' ( OTCPK:SMPQY ) XELPROS (latanoprost ophthalmic emulsion) 0.005% for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. More news on: Sun Pharmaceuticals Industries Ltd. ADR, Aerie Pharmaceuticals, Inc...
Nicox ( OTCPK:NICXF ): 1H net loss of €7.6M More news on: NICOX SA EUR ORD NEW, Earnings news and commentary, Healthcare stocks news, , Read more ...
Welcome to another edition of "3 Things In Biotech," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. Bristol-Myers marches on in European melanoma care Company: Bristol-Myers Squibb ( BMY ) Therapy: Nivolumab Di...
The following slide deck was published by NICOX SA EUR ORD NEW in conjunction with this Read more ...
Nicox ( OTCPK:NICXF ): Q2 Revenue of €0.26M More news on: NICOX SA EUR ORD NEW, Earnings news and commentary, Healthcare stocks news, , Read more ...
Nicox ( OTCPK:NICXF ): Q1 Revenue of €0.075M More news on: NICOX SA EUR ORD NEW, Earnings news and commentary, Healthcare stocks news, , Read more ...
The following slide deck was published by NICOX SA EUR ORD NEW in conjunction with this Read more ...
The following slide deck was published by NICOX SA EUR ORD NEW in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
Nicox SA Company Name:
NICXF Stock Symbol:
OTCMKTS Market:
Attachment EN_DenaliLastUSPatient_PR_FINAL
Attachment EN_Nicox Conferences 2024_FINAL
1 Net revenue consists of revenue from collaborations less royalty payments 2 Intra-ocular pressure Attachment EN_Q22024Results_PR_FINAL